Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy

被引:46
|
作者
Visentin, Andrea [1 ,2 ]
Compagno, Nicolo [1 ,2 ]
Cinetto, Francesco [1 ,2 ]
Imbergamo, Silvia [1 ]
Zambello, Renato [1 ,2 ]
Piazza, Francesco [1 ,2 ]
Semenzato, Gianpietro [1 ,2 ]
Trentin, Livio [1 ,2 ]
Agostini, Carlo [1 ,2 ]
机构
[1] Univ Padua, Sch Med, Dept Med, Hematol & Clin Immunol Branch, I-35100 Padua, Italy
[2] Ctr Eccellenza Ric Biomed Avanzata, Venetian Inst Mol Med, Milan, Italy
关键词
CLL; infections; secondary hypogammaglobulinemia; hypogammaglobulinemia; immunoglobulin replacement therapy; HYPOGAMMAGLOBULINEMIA; COMPLICATIONS; GUIDELINES; DIAGNOSIS; SECONDARY; DISEASE;
D O I
10.3324/haematol.2015.126763
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E515 / E518
页数:4
相关论文
共 50 条
  • [1] Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
    Noto, Alessandro
    Cassin, Ramona
    Mattiello, Veronica
    Bortolotti, Marta
    Reda, Gianluigi
    Barcellini, Wilma
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [2] Antibody Deficiency Secondary to Chronic Lymphocytic Leukemia: Should Patients be Treated with Prophylactic Replacement Immunoglobulin?
    Dhalla, Fatima
    Lucas, Mary
    Schuh, Anna
    Bhole, Malini
    Jain, Rashmi
    Patel, Smita Y.
    Misbah, Siraj
    Chapel, Helen
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (03) : 277 - 282
  • [3] Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia
    Mauro, Francesca R.
    Morabito, Fortunato
    Vincelli, Iolanda D.
    Petrucci, Luigi
    Campanelli, Melissa
    Salaroli, Adriano
    Uccello, Giuseppina
    Petrungaro, Annamaria
    Ronco, Francesca
    Raponi, Sara
    Nanni, Mauro
    Neri, Antonino
    Ferrarini, Manlio
    Guarini, Anna R.
    Foa, Robin
    Gentile, Massimo
    LEUKEMIA RESEARCH, 2017, 57 : 65 - 71
  • [4] Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia
    Mustafa, S. Shahzad
    Jamshed, Saad
    Vadamalai, Karthik
    Ramsey, Allison
    PLOS ONE, 2021, 16 (10):
  • [5] Antibody Deficiency Secondary to Chronic Lymphocytic Leukemia: Should Patients be Treated with Prophylactic Replacement Immunoglobulin?
    Fatima Dhalla
    Mary Lucas
    Anna Schuh
    Malini Bhole
    Rashmi Jain
    Smita Y. Patel
    Siraj Misbah
    Helen Chapel
    Journal of Clinical Immunology, 2014, 34 : 277 - 282
  • [6] Bacterial Colonization in Patients with Chronic Lymphocytic Leukemia and Factors Associated with Infections and Colonization
    Korona-Glowniak, Izabela
    Grywalska, Ewelina
    Grzegorczyk, Agnieszka
    Rolinski, Jacek
    Glowniak, Andrzej
    Malm, Anna
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (06)
  • [7] Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia
    Svensson, Tobias
    Hoglund, Martin
    Cherif, Honar
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 45 (07) : 537 - 542
  • [8] IMMUNOGLOBULIN REPLACEMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) - KINETICS OF IMMUNOGLOBULIN METABOLISM
    CHAPEL, HM
    LEE, M
    JOURNAL OF CLINICAL IMMUNOLOGY, 1992, 12 (01) : 17 - 20
  • [9] A Canadian perspective on the use of immunoglobulin therapy to reduce infectious complications in chronic lymphocytic leukemia
    Lachance, S.
    Christofides, A. L.
    Lee, J. K.
    Sehn, L. H.
    Ritchie, B. C.
    Shustik, C.
    Stewart, D. A.
    Toze, C. L.
    Haddad, E.
    Vinh, D. C.
    CURRENT ONCOLOGY, 2016, 23 (01) : 42 - 51
  • [10] Immunoglobulin substitution in patients with secondary antibody deficiency in chronic lymphocytic leukemia and multiple myeloma: a representative analysis of guideline adherence and infections
    Link, Hartmut
    Kerkmann, Markus
    Holtmann, Laura
    SUPPORTIVE CARE IN CANCER, 2022, 30 (06) : 5187 - 5200